Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation

Europace

Volumn 14, Issue 12, 2012, Pages 1759-1763

  Schroeter, Thomas ^a   Linke, Axel ^a   Haensig, Martin ^a   Merk, Denis R ^a   Borger, Michael A ^a   Mohr, Friedrich W ^a   Schuler, Gerhard ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Aortic valve stenosis; Atrio ventricular block; Pacemaker; Trans catheter aortic valve replacement

Indexed keywords

AGE; AGED; AORTA VALVE PROSTHESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR MORTALITY; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART ATRIUM FIBRILLATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; BIOPROSTHESIS; COMORBIDITY; ELECTRODES, IMPLANTED; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROGNOSIS; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84870228950     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus191     Document Type: Article

References (26)

1. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703. (Pubitemid 38229547)
2. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D et al. Treatment of calcific aortich stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-23.
3. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve Prosthesis. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
4. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-50.
5. Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 2008;1:74-81.
6. Bleiziffer S, Ruge H, Horer J, Mazzitelli D, Schreiber C, Hutter A et al. Postoperative AV block and pacemaker implantation after transcatheter aortic valve implantation. Circulation 2008;118:S904-5.
7. Mantel N, Haenzel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
8. 2 tests. Biometrics 1954;10:417-51.
9. Guetta V, Goldenberg G, Segev A, Dvir D, Kornowski R, Finckelstein A et al. Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol 2011;108: 1600-5.
10. Dawkins S, Hobson AR, Kalra PR, Tang AT, Monro JL, Dawkins KD. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications and predictors. Ann Thorac Surg 2008;85:108-12. (Pubitemid 350284581)
11. Gordon RS, Ivanov J, Cohen G, Ralph-Edwards AL. Permanent cardiac pacing after cardiac operation: predicting the use of permanent pacemakers. Ann Thorac Surg 1998;66:1698-704. (Pubitemid 29030174)
12. Limongelli G, Ducceschi V, D'Andrea A, Renzulli A, Sarubbi B, De Feo M et al. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart 2003;89:901-4. (Pubitemid 36920817)
13. Elahi J, Usmaan K. The bioprosthesis type and size influence the postoperative incidence of permanent pacemaker implantation in patients undergoing aortic valve surgery. J Interv Card Electrophysiol 2006;15:113-8. (Pubitemid 43854360)
14. Habicht JM, Scherr P, Zerkowski HR, Hoffmann A. Late conduction defects following aortic valve replacement. J Heart Valve Dis 2000;9:629-32.
15. Erkapic D, Kim WK, Weber M, Möllmann H, Berkowitsch A, Zaltsberg S et al. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 2010;12:1180-90.
16. Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Martin P. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. J Am Coll Cardiol Intv 2008;1:305-9. (Pubitemid 351816793)
17. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006;114:1616-24. (Pubitemid 44547432)
18. Jilaihawi H, Chin D, Vasa-Nicotera M, Jeilan M, Spyt T, Andre G et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009;157:860-6.
19. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
20. Nuis RJ, Piazza N, Van Mieghem NM, Otten AM, Tzikas A, van der Boon R et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 2011;78:457-67.
21. Bleiziffer S, Ruge H, Hörer J, Hutter A, Geisbüsch S, Brockmann G et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. J Am Coll Cardiol Intv 2010;3:524-30.
22. Latsios G, Gerckens U, Buellesfeld L, Mueller R, John D, Yuecel S et al. 'Device landing zone' calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 2010;76:431-9.
23. Calvi V, Puzzangara E, Pruiti GP, Conti S, Di Grazia A, Ussia GP et al. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 2009;32(Suppl. 1):S126-30.
24. John D, Buellesfeld L, Yuecel S, Mueller R, Latsios G, Beucher H et al. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantation with the self-expanding Core-Valve prosthesis. JACC Cardiovasc Interv 2010;3:233-43.
25. Messika-Zeitoun D, Aubry MC, Detaint D, Bielak LF, Peyser PA, Sheedy PF et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004;110:356-62. (Pubitemid 38955506)
26. Feuchtner GM, Müller S, Grander W, Alber HF, Bartel T, Friedrich GJ et al. Aortic valve calcification as quantified with multislice computed tomography predicts short-term clinical outcome in patients with asymptomatic aortic stenosis. J Heart Valve Dis 2006;15:494-8. (Pubitemid 44122677)